Bibliographie

Publié le 07/11/2014

Article réservé aux abonnés

1- Lue TF Erectile dysfunction N Engl J Med. 2000;342(24):1802-13

2- Giuliano F., Leriche A., Jaudinot E., Solesse de Gendre A. Prevalence of Erectile Dysfunction Among 7689 Patients With Diabetes, Hypertension, or Both Urology 2004;64(6):1196-201

3- Karavitakis M, Komninos C, Theodorakis PN, Politis V, Lefakis G, Mitsios K, Koritsiadis S, Doumanis G. Evaluation of sexual function in hypertensive men receiving treatment: a review of current guidelines recommendation. J Sex Med. 2011;8(9):2405-14

4- Grimm RH Jr, Grandits GA, Prineas RJ, et al. Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS) Hypertension. 1997;29(1 Pt 1):8-14

5- Manolis A, Doumas M. Antihypertensive treatment and sexual dysfunction Curr Hypertens Rep. 2012;14(4):285-92

6- Shindel AW, Kishore S, Lue TF. Drugs designed to improve endothelial function: effects on erectile dysfunction. Curr Pharm Des. 2008;14(35):3758-67

7- Ekselius L, Von Knorring L. Effect on sexual function of long-term treatment with selective serotonin reuptake inhibitors in depressed patients treated in primary care. J Clin Psychopharmacol. 2001; 21(2):154-60.

8- Labbate LA, Croft HA, Oleshansky MA. Antidepressant-related erectile dysfunction: management via avoidance, switching antidepressants, antidotes, and adaptation. J Clin Psychiatry. 2003;64 Suppl 10:11-9.

9- Montejo AL, Llorca G, Izquierdo JA, Rico-Villademoros F. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related SexualDysfunction. J Clin Psychiatry. 2001;62 Suppl 3:10-21

10-Labbate LA et al. J Clin Psychiatry. 2003;64 Suppl 10:11-9.

11- Tsakiris P, Oelke M, Michel MC. Drug-induced urinary incontinence. Drugs Aging. 2008;25(7):541-9.

12- Rosen RC, Lane RM, Menza M. Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol. 1999 Feb;19(1):67-85

13- Giuliano F et Droupy S, Sexual side effects of pharmacological treatments Prog Urol. 2013 Jul;23(9):804-10

14- Serretti A, Chiesa A. A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics Int Clin Psychopharmacol. 2011;26(3):130-40

15- Kaufman KR, Struck PJ. Gabapentin-induced sexual dysfunction. Epilepsy Behav. 2011;21(3):324-6

16-Bostwick M, Hecksel KA, Stevens SR, Bower JH, Ahlskog JE. Frequency of New-Onset Pathologic Compulsive Gambling or Hypersexuality After Drug Treatment of Idiopathic Parkinson. Disease Mayo Clin Proc. April 2009;84(4):310-316)

17-Rizvi K, Hampson JP, Harvey JN. Do lipid-lowering drugs cause erectile dysfunction ? A systematic review. Fam Pract. 2002 Feb;19(1):95-8.

18-Saltzman E A, guay AT, Jacobson J. Improvement in erectile function in men with organic erectile dysfunction by correction of elevated cholesterol levels: a clinical observation. J Urol 2004;172: 257-258

19-Colson AE, Keller MJ, Sax PE, Pettus PT, Platt R, Choo PW. Male sexual dysfunction associated with antiretroviral therapy. J Acquir Immune Defic Syndr. 2002 May 1;30(1):27-32

20- Giuliano F. Impact of medical treatments for benign prostatic hyperplasia on sexual function BJU International 2006, 97 (s2), 34-38

21- Rosen R., Altwein J., Boyle P., Kirby R. S., Lukacs B., Meuleman E., O'Leary M. P., Puppo P., Robertson C., Giuliano F. Lower Urinary Tract Symptoms and Male Sexual Dysfunction: The Multinational Survey of the Aging Male (MSAM-7), Eur.Urol. 2003, 44 (6) : 637-649

22- Costa P, Sarrazin B, Bressolle F, Colson MH, Bondil P, Saudubray F. Efficiency and side effects of intracavernous injections of moxisylyte in impotent patients: a dose-finding study versus placebo. J Urol. 1993;149(2):301-5

23- Oelke M., Giuliano F.; Mirone V., Xu L., Cox D., Viktrup L. Tadalafil or tamsulosin in the treatment of Lower Urinary Tract Symptoms in men with Benign Prostatic Hyperplasia : a Phase 3, Multicenter, Double-Blind, Randomized, Placebo- -Controlled Trial Eur. Urol. 2012;61(5):917-25

24- Carbone DJ Jr, Hodges S. Medical therapy for benign prostatic hyperplasia: sexual dysfunction and impact on quality of life. Int J Impot Res. 2003,15(4):299-306 Giuliano F. Impact of medical treatments for benign prostatic hyperplasia on sexual function BJU International 2006, 97 (s2), 34-38

25- Roehrborn CG, Siami P, Barkin J, Damião R, Major-Walker K, Nandy I, Morrill BB, Gagnier RP, Montorsi F. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study Eur Urol. 2010 ;57(1):123-31

26- Roehrborn CG, Kaplan SA, Lepor H, Volinn W. Symptomatic and urodynamic responses in patients with reduced or no seminal emission during silodosin treatment for LUTS and BPH Prostate Cancer Prostatic Dis. 2011 Jun;14(2):143-8

27- Mills TM, Lewis RW. The role of androgens in the erectile response: a 1999 perspective. Mol Urol 1999; 3:75-86

28- Iversen P, Melezinek I, Schmidt A. Nonsteroidal antiandrogens: a therapeutic option for patients with advanced prostate cancer who wish to retain sexual interest and function. BJU Int. 2001;87(1):47-56

29- Iversen P, Melezinek I, Schmidt A. Nonsteroidal antiandrogens: a therapeutic option for patients with advanced prostate cancer who wish to retain sexual interest and function. BJU Int. 2001 ;87(1):47-56

30- Schroder FH, Collette L, De Reike TM, Whelan P. Prostate cancer treated by anti-androgens: is sexual function preserved? EORTC Genitourinary Group. European Organization for Research and Treatment of Cancer Br J Cancer. 2000 ;82(2):283-90

31- Brock GB, Lue TF. Drug-induced male sexual dysfunction. An update. Drug Saf 1993;8:414-26 Finger WW, Lund M, Slagle MA. Medications that may contribute to sexual disorders: a guide to assessment and treatment in family practice. J Fam Pract 1997;44(1):33-43

32- Walsh, P. C. and Donker, P. J.: Impotence following radical prostatectomy: insight into etiology and prevention. J Urol, 128: 492, 1982.

33- Schover L R, Fouladi R T, Warneke C L, Neese L, Klein E, Zippe C, Kupelian P, Defining Sexual Outcomes after Treatment for Localized Prostate Carcinoma. Cancer 2002, 15 (8); 95, 1773-1785.

34- Wu A.K, Cooperberg M R, Sadetsky N and Carroll PR. Health Related Quality of Life in Patients Treated With Multimodal Therapy for Prostate Cancer. J Urol 2008; 180, 2415-2422.